pharmaceutical preparations for the treatment of cystic fibrosis, pulmonary diseases, acute and chronic infections, gastrointestinal disorders, for th Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis, pulmonary diseases, acute and chronic infections, gastrointestinal disorders, for the prevention and disruption of microbial biofilms, and for wound care.

Classification kind code

Mark Details

Serial Number

1799899

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 50 on 09^th Nov 2018	Allowed
Submitted for opposition 42 on 25^th Jul 2018	Advertised
Submitted for opposition 26 on 05^th Jul 2018	Approved
Submitted for opposition 27 on 16^th May 2018	Approval Notice Sent
Submitted for opposition 12 on 16^th Oct 2017	Extension of Time
Submitted for opposition 22 on 06^th Apr 2017	Search Recorded
Submitted for opposition 20 on 06^th Apr 2017	Examiner's First Report
Submitted for opposition 31 on 14^th Sep 2016	Formalized
Submitted for opposition 1 on 13^th Sep 2016	Created
Submitted for opposition 30 on 12^th Sep 2016	Filed

ALGIPHARMA

Classification Information

Class [005]Pharmaceutical preparations for the treatment of cystic fibrosis, pulmonary diseases, acute and chronic infections, gastrointestinal disorders, for the prevention and disruption of microbial biofilms, and for wound care.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis, pulmonary diseases, acute and chronic infections, gastrointestinal disorders, for the prevention and disruption of microbial biofilms, and for wound care.